Kura Oncology, Inc. · NASDAQ:KURA
BVF PARTNERS L P/IL reported a 7.50% stake in Kura Oncology, Inc. (Schedule 13G)
Event Jan 27, 2025 · Filed Feb 4, 2025
BVF PARTNERS L P/IL reported a 7.50% stake in Kura Oncology, Inc., 5,912,554 shares, as a passive investor on Jan 27, 2025. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 7.50%
- Shares
- 5,912,554
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.90% | 3,041,280 |
| BVF I GP LLC | 3.90% | 3,041,280 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.10% | 2,451,183 |
| BVF II GP LLC | 3.10% | 2,451,183 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 306,446 |
| BVF Partners OS Ltd. | 0.40% | 306,446 |
| BVF GP HOLDINGS LLC | 7.00% | 5,492,463 |
| BVF PARTNERS L P/IL | 7.50% | 5,912,554 |
| BVF INC/IL | 7.50% | 5,912,554 |
| LAMPERT MARK N | 7.50% | 5,912,554 |
Source
Related
- Kura Oncology, Inc.
- Bvf Partners L P
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Nov 14, 2025
- Schedule 13G/A · Bvf Partners L P · Feb 4, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026